NL-OMON27839
Recruiting
Not Applicable
A prospective study to evaluate the long-term effectiveness, safety, and performance of the Saluda Medical’s EvokeTM Closed-Loop Spinal Cord Stimulation System incorporating feedback control to treat patients with chronic pain of the trunk and/or limbs
Saluda Medical0 sites70 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Saluda Medical
- Enrollment
- 70
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Evaluate the effectiveness of the Evoke System.
Exclusion Criteria
- •Evaluate the safety of the Evoke System
- •Evaluate the performance of the Evoke System.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Prospective observational study on long-term results after glaucoma surgeryH40.1Primary open-angle glaucomaDRKS00033556Augeklinik und Poliklinik, Universitätsmedizin der Johannes Gutenberg-Universität Mainz2,535
Recruiting
Not Applicable
Prospective observational study on long-term results after glaucoma surgery - substudy: endothelial cell count following Paul Glaucoma Implant surgeryH40GlaucomaDRKS00033596Augeklinik und Poliklinik, Universitätsmedizin der Johannes Gutenberg-Universität Mainz62
Completed
Not Applicable
Prospective cohort study evaluating the long-term outcome after endoscopic submucosal dissection for colorectal neoplasia.Colorectal neoplasia can be treated endoscopicallyJPRN-UMIN000010136ational cancer center hospital1,400
Not yet recruiting
Not Applicable
A prospective longitudinal study to assess the relation between patient characteristics and the duration of use in patients who start Selective Serotonin Reeuptake Inhibotor treatment.depression10027946NL-OMON30193niversiteit Utrecht170
Active, not recruiting
Not Applicable
Clinical Study to Investigate the Long-Term Efficacy, Safety, and Immunogenicity of human-cl rhFVIII in Previously Treated Patients with Severe Haemophilia A – Extension Study to GENA-01Severe haemophilia A (FVIII:C <1%)MedDRA version: 12.1Level: LLTClassification code 10018937Term: Haemophilia AEUCTR2010-023242-69-DEOctapharma AG25